New Treatment for Trial on UK COVID Patients


A new antibody treatment is to be trialled on Covid-19 patients in UK hospitals.
Monoclonal antibodies, which are potent, laboratory-made antibodies, will be given to about 2,000 people to see if they are effective against coronavirus.

It forms part of the UK Recovery Trial, which found that a cheap steroid called “dexa-metha-sone” could save lives.

The first patients will be given the new drugs in the coming weeks.